The genetic basis of antibiotic resistance in 113 unrelated group B streptococci was studied by PCR. Ninety-four strains were resistant to tetracycline-minocycline, and tet(M) was detected in 85% of these isolates. Seventeen erythromycin-resistant strains contained the erm(B), erm(TR), or mef(A) gene. Eleven strains exhibited high-level resistance to kanamycin due to the presence of the aphA3 gene; eight of these strains were also highly resistant to streptomycin; aad-6-related sequences were detected in seven strains.
(n ϭ 3). During this 2-year period, the rates of antibiotic resistance remained stable. The percentages of strains resistant to TC, macrolides-lincosamides-streptogramin B (MLS), and high levels of kanamycin (KM) were 85, 15, and 10, respectively. All strains were susceptible to penicillin, ampicillin, cefotaxime, vancomycin, teicoplanin, and rifampin and exhibited low-level resistance to gentamicin. The distribution of GBS capsular serotypes was also stable during our study: Ia, 15%; Ib, 6%; II, 8%; III, 39%; V, 20%; nongroupable, 12%. It has been shown that the distribution of GBS capsular serotypes is influenced by the type of infection (noninvasive versus invasive) and the patient type (neonate versus adult) (4) . Accordingly, the 20 strains of our collection isolated from blood cultures (n ϭ 17) or cerebrospinal fluid (n ϭ 3) belong to either serotype III (75%) or V (25%). Since 1990, serotypes III, I, and V have been the most prevalent serotypes recovered from invasive infections (4) . Serotype V was the most common serotype recovered from nonpregnant adults with invasive GBS disease and the second and third most common serotype recovered from pregnant women and neonates with early-onset disease (4) . Therefore, our results reflect these contemporary trends. No association between sample origin and susceptibility to antibiotics was found. However, 45% of the MLS-resistant strains belonged to type V. This finding confirms previous data (12) suggesting that antibiotic resistance is more frequently encountered in strains of serotype V than in strains of other serotypes.
The second aim of our study was to determine, by PCR amplification, the genetic basis of antibiotic resistance in GBS. This was done with a sampling of 113 unrelated isolates representative of the 664 GBS strains isolated during the 2-year survey period. These 113 GBS strains were all isolates excluding duplicates obtained during a 4-month period from urine samples (n ϭ 50), genital specimens from pregnant women and nonpregnant adults (n ϭ 33), gastric fluid or ear specimens from colonized or infected newborns (n ϭ 15), pus from different origins (n ϭ 12), blood cultures (n ϭ 2), and cerebrospinal fluid (n ϭ 1). The antibiotic resistance rate of this sampling was similar to that observed during the 2-year survey, and the serotype distribution was almost identical to that of the 664 strains isolated during the 2-year period (Ia, 14%; Ib, 8%; II, 9%; III, 37%; V, 18%; nongroupable, 14%).
We first examined the genetic diversity of the 113 selected strains by pulsed-field gel electrophoresis (PFGE) as previously described (22) . Chromosomal DNAs were digested with restriction enzyme BssHII or SmaI and separated with a BioRad contour-clamped homogeneous electric field mapper with a switch time of 5 to 35 s for 22 h at a 120°angle with a voltage gradient of 6 V/cm at 14°C. PFGE banding patterns were compared by using a computer system (Biocapt; Vilmer Lourmat). Cluster analysis (unweighted pair group average) was used to calculate similarity and dissimilarity among GBS isolates. A difference was considered significant if the similarity coefficient was Ͻ60%. PFGE typing of the 113 strains yielded 19 distinct patterns and a total of 90 pulsotypes (data not shown). Fifty percent of the type V strains were highly related and clustered within the same pattern ( Fig. 1 shows part of this analysis). This pattern was almost identical to that of the predominant French type V clone, which is clonally related to the predominant U.S. serotype V GBS strain ( Fig. 1) (11, 18, 19) .
Screening for antibiotic susceptibility was performed as described above. The resistance phenotypes of EM-resistant GBS strains were determined by the double-disk test with EM and CM disks as previously described (25) . Resistance to both EM and CM indicated a constitutive MLS resistance phenotype, and blunting of the CM inhibition zone proximal to the EM disk indicated an inducible MLS resistance phenotype. Resistance to EM and susceptibility to CM with no blunting suggested an M phenotype. The MICs were determined by the agar dilution method in Mueller-Hinton broth, and the plates were incubated under air at 37°C. Categorization was done on the basis of the following Comité de l'Antibiogramme de la Société Française de Microbiologie breakpoints: EM and CM, Ն4 g/ml, TC and minocycline (MN), Ͼ8 g/ml, penicillin, Ն8 g/ml, KM and streptomycin (SM), Ͼ250 g/ml (8) . All of the strains were susceptible to penicillin, vancomycin, teicoplanin, and rifampin and exhibited low-level resistance to gentamicin (data not shown). The MICs of the antibiotics tested for the 113 strains tested are shown in Table 1 (Table 2) . MLS and aminoglycoside resistances were always associated with TC-MN resistance. We searched for the presence of antibiotic resistance genes by PCR. Total DNAs were extracted by using the Instagene matrix (Bio-Rad), and PCR amplifications were performed as previously described (22) . The primers used to amplify the various TC, EM, KM, and SM resistance determinants and the sizes of the amplicons are listed in Table 3 . Amplification of DNA from positive controls with the corresponding primers yielded PCR products of the expected size (data not shown). Table 2 ). The tet(K) and tet(S) determinants were not detected. The tet(T) determinant, originally detected in Streptococcus pyogenes (7), was found for the first time in S. agalactiae. Combination of TC resistance determinants has been reported previously in various gram-positive bacteria and in S. agalactiae (24) . tet(M) is the most prevalent resistance determinant, accounting for TC resistance in gram-positive bacteria (24) is often associated with conjugative elements of the Tn916 family (24) . Consistently, the int-Tn gene, encoding the integrase of Tn916, was found in 88% of the strains harboring tet(M). These results demonstrate that TC resistance in GBS is due to the acquisition of Tn916-related transposons. The reason why Tn916-mediated TC resistance is so widely disseminated in GBS, compared to other streptococcal or enterococcal species, remains unclear since these bacteria are exposed to similar antibiotic selective pressures. Fifteen percent of the strains studied exhibited decreased susceptibility to EM. In streptococci, two major mechanisms accounting for resistance to MLS antibiotics are recognized. Cross-resistance to all MLS antibiotics is due to methylation of the 23S rRNA by a methyltransferase encoded by an erm (EM No. of positive PCR amplifications with specific primers for following resistance gene: Susceptible  19  0  0  0  0  0  0  0  0  0  1  Tc  r Mn   r   74  67  6  1  2  0  0  0  0  0  64  Tc resistance methylase) gene (17) . Resistance to 14-and 15-member macrolides is mediated by a proton-dependent active drug efflux system encoded by the mef (macrolide efflux) gene (6) . We searched for the presence of sequences related to erm(B), erm(A/TR), erm(C), and mef(A) by PCR. The merA gene, initially described as a macrolide efflux determinant but now known to encode a riboflavin kinase in all GBS strains, was used as a PCR positive control (5). The MLS resistance phenotype was due to the presence of the erm(B) and erm(TR) genes, which were distributed differently in strains expressing resistance constitutively (90.5 and 9.5%, respectively) or inducibly (10 and 90%, respectively). The strain exhibiting an M phenotype harbored the mef(A) gene ( Table 2 ). The erm(C) determinant was not detected. Combinations of EM resistance determinants were not found in our study as previously reported in S. pneumoniae and S. pyogenes and more recently in S. agalactiae (3, 9, 10, 13) . Our results confirm that the erm(B) gene and, to a lesser extent, erm(TR) are widely distributed among GBS strains. In contrast, the mef(A) gene is rare among GBS compared to S. pyogenes or other beta-hemolytic streptococci (15) . Finally, our study shows that the presence of erm(TR) was encountered significantly (P Ͻ 0.02) more frequently in strains belonging to serotype V than in strains of other serotypes (data not shown). This observation may simply reflect the clonality of the type V strains in our sampling. Eleven strains show HLR-KM, and as previously shown in streptococci and enterococci, this resistance phenotype is due to the presence of aphA3 (20) . Among these 11 strains, 8 were also highly resistant to SM and sequences related to the aad-6 gene were detected in 7 strains ( Table 2 ). The SM resistance of the remaining strain was probably due to a chromosomal mutation(s).
In conclusion, our results show that TC resistance due to the presence of tet(M) and conjugative transposons such as Tn916 was detected in at least 80% of the GBS strains studied. Most importantly, EM and CM resistance was detected in 15% of the strains. These results emphasize the need to monitor the epidemiology and genetic basis of antibiotic resistance in GBS.
